Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122312
Filing Date
2024-11-06
Accepted
2024-11-06 16:11:39
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sera-20240930.htm   iXBRL 10-Q 2560948
2 EX-31.1 sera-ex31_1.htm EX-31.1 13753
3 EX-31.2 sera-ex31_2.htm EX-31.2 13784
4 EX-32.1 sera-ex32_1.htm EX-32.1 9302
  Complete submission text file 0000950170-24-122312.txt   9828008

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sera-20240930.xsd EX-101.SCH 1098397
76 EXTRACTED XBRL INSTANCE DOCUMENT sera-20240930_htm.xml XML 2063792
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40606 | Film No.: 241431053
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)